These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8283177)

  • 1. Transfer of humoral immunity against cytomegalovirus proteins following transplantation of T-cell-depleted allogeneic bone marrow from seropositive donors.
    Roy DM; Brenner MK; Cook D; Duncan RI; Griffiths PD; Grundy JE
    J Med Virol; 1993 Oct; 41(2):150-8. PubMed ID: 8283177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
    Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
    Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients.
    Schoppel K; Schmidt C; Einsele H; Hebart H; Mach M
    J Infect Dis; 1998 Nov; 178(5):1233-43. PubMed ID: 9780241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E; Ward KN; Szydlo R; Goldman JM
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients.
    Zaia JA; Forman SJ; Ting YP; Vanderwal-Urbina E; Blume KG
    J Infect Dis; 1986 Apr; 153(4):780-7. PubMed ID: 3005437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection.
    van Zanten J; van der Giessen M; van Son WJ; The TH
    J Med Virol; 1993 Jan; 39(1):80-7. PubMed ID: 8380844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
    Boland GJ; Vlieger AM; Ververs C; De Gast GC
    Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro.
    Greenberg PD; Reusser P; Goodrich JM; Riddell SR
    Ann N Y Acad Sci; 1991 Dec; 636():184-95. PubMed ID: 1665321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
    N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
    Landini MP; Rossier E; Schmitz H
    J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of anti-cytomegalovirus antibody following T-cell depleted bone marrow transplant.
    Wimperis JZ; Berry NJ; Brenner MK; Grundy J; Hoffbrand AV; Griffiths PD; Prentice HG
    Br J Haematol; 1986 Aug; 63(4):659-64. PubMed ID: 3015192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus immunity in allogeneic marrow grafting.
    Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
    Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
    Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Ikuta K; Kushida N; Yanagida T; Shishido K; Aikawa K; Toma H; Inoue N; Yamaguchi O; Tanabe K; Suzutani T
    Transpl Infect Dis; 2011 Jun; 13(3):318-23. PubMed ID: 20804536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease.
    Gratama JW; Fibbe WE; Naipal AM; Slats J; Stijnen T; D'Amaro J; Bolhuis RL; The TH; Janssen J
    Bone Marrow Transplant; 1986 Dec; 1(2):141-6. PubMed ID: 2844332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.
    van der Heiden PLJ; van Egmond HM; Veld SAJ; van de Meent M; Eefting M; de Wreede LC; Halkes CJM; Falkenburg JHF; Marijt WAF; Jedema I
    Transpl Immunol; 2018 Aug; 49():54-58. PubMed ID: 29679650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.